Geneos Wealth Management’s Arconic Corporation ARNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-620
Closed -$18.3K 2156
2023
Q2
$18.3K Hold
620
﹤0.01% 1409
2023
Q1
$16.3K Hold
620
﹤0.01% 1406
2022
Q4
$13.1K Sell
620
-83
-12% -$1.74K ﹤0.01% 1457
2022
Q3
$11K Sell
703
-561
-44% -$14.6K ﹤0.01% 1502
2022
Q2
$35K Sell
1,264
-61
-5% -$1.65K ﹤0.01% 1443
2022
Q1
$33K Sell
1,325
-66
-5% -$1.96K ﹤0.01% 1565
2021
Q4
$45K Hold
1,391
﹤0.01% 1527
2021
Q3
$45K Hold
1,391
﹤0.01% 1547
2021
Q2
$49K Buy
1,391
+103
+8% +$3.4K ﹤0.01% 1496
2021
Q1
$36K Buy
1,288
+16
+1% +$429 ﹤0.01% 1802
2020
Q4
$23K Buy
1,272
+287
+29% +$7.55K ﹤0.01% 1837
2020
Q3
$18K Hold
985
﹤0.01% 1713
2020
Q2
$13K Buy
+985
New +$11.5K ﹤0.01% 1822

Other funds holding ARNC

Geneos Wealth Management's ARNC Position: Q3 2023 in Review

Geneos Wealth Management sold out of Arconic Corporation (ARNC) in Q3 2023, closing a stake of 620 shares — an estimated $18.3K sold.

Geneos Wealth Management first reported a position in ARNC in Q2 2020 and held it in 13 quarters. The position peaked at $49K in Q2 2021. 5 funds tracked by Wall St. Rank hold ARNC as of Q3 2023.

  • Geneos Wealth Management reported no remaining Arconic Corporation position as of Q3 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 620 Arconic Corporation shares in Q3 2023, an estimated $18.3K.
  • Geneos Wealth Management first reported a position in Arconic Corporation in Q2 2020 and held it in 13 quarters.
  • Geneos Wealth Management's Arconic Corporation position peaked at $49K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Arconic Corporation as of Q3 2023.

Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.